US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bemis

57.25

+0.0000

Volume:- -

Turnover:- -

Market Cap:5.22B

PE:22.68

High:57.25

Open:57.25

Low:57.25

Close:57.25

Loading ...

Overview Company News Filings

VEEA and MARQUEE Wireless Announce a Strategic Partnership that Extends Cellular Networks with Groundbreaking Smart City and Smart Energy Applications

Press Release: Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

Press Release: IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer

Press Release: Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates

NXP Announces Industry-First Ultra-Wideband Wireless Battery Management System Solution

Li-S Energy off like a rocket on latest breakthrough

Redwire Announces Spaceflight Mission with Bristol Myers Squibb to Study Small Molecule Drug Compounds, Launching Additional Biopharma Investigations to Study Bone Disease Treatments in Space

At electronica 2024, Alpha and Omega Semiconductor to Showcase its Application-Specific Solutions for Auto, Industrial, Power Supplies, Renewable Energy, e-Mobility and More

JOHNSON CONTROLS TO SHOWCASE SMARTER, SAFER, AND MORE RESILIENT DATA CENTRE SOLUTIONS AT DATA CENTRE WORLD ASIA 2024

Leidos touts small cruise missile solution, announces successful test accomplishments

Shattuck Labs Shutters Cancer Program, Lays Off Around 40% Of Its Workforce, Reorganizes Pipeline

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BMS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMS\",,,,,undefined,":{"symbol":"BMS","market":"US","secType":"STK","nameCN":"Bemis","latestPrice":57.25,"timestamp":1569009600000,"preClose":57.25,"halted":0,"volume":0,"delay":0,"floatShares":90294980,"shares":91211990,"eps":2.5238,"marketStatus":"Post-Market Trading","change":0,"latestTime":"03-27 19:10:56 EDT","open":57.25,"high":57.25,"low":57.25,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.5238,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1743120000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":57.25,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMS\",,,,,undefined,":{"symbol":"BMS","floatShares":90294980,"roa":"--","roe":"--","lyrEps":2.480219,"shares":91211990,"dividePrice":1.28,"high":57.25,"amplitude":0,"preClose":57.25,"low":57.25,"week52Low":40.86,"pbRate":"4.18","week52High":59.85,"institutionHeld":0.7014,"latestPrice":57.25,"eps":2.5238,"divideRate":0.022358,"volume":0,"delay":0,"ttmEps":2.5238,"open":57.25,"prevYearClose":57.25},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMS\",pageSize:16,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2486065989","title":"VEEA and MARQUEE Wireless Announce a Strategic Partnership that Extends Cellular Networks with Groundbreaking Smart City and Smart Energy Applications","url":"https://stock-news.laohu8.com/highlight/detail?id=2486065989","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486065989?lang=en_us&edition=fundamental","pubTime":"2024-11-26 05:30","pubTimestamp":1732570200,"startTime":"0","endTime":"0","summary":"SMARTCELLs with integrated Veea Edge Platform offer a practical solution for collection and processing of massive amounts of data for highly unique AI-driven edge applications. Visit our Booth #510 at Smart Cities Connect Conference in Austin, TX, December 3-5, 2024. \"It is a pleasure to work with the Veea team to extend the capabilities of our revolutionary, modular SMARTCELL platform for cellular networks and Smart Cities with IoT, Mobile-Edge computing and AI,\" said Dimitrios Lalos, MARQUEE’s founder and CEO. \"The MARQUEE team is pioneering advancements in the deployment of cellular solutions enhanced with innovative, fully patented technology. Our combined knowledge, expertise and products will make its mark for the cellular industry together with Veea’s first-of-a-kind technologies in AI-driven cybersecure connectivity with network slicing to protect the Smart City endpoints at the edge, and preserve data privacy by processing raw data for innovative applications with Edge AI loca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/veea-marquee-wireless-announce-strategic-213000047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CC","VEEAW","MEC","VEEA","CHCO","BMS","BK4161","BK4211","BK4563","BK4098","BK4023"],"gpt_icon":0},{"id":"2484629090","title":"Press Release: Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2484629090","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484629090?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:30","pubTimestamp":1731933000,"startTime":"0","endTime":"0","summary":"Promotes Edward Brennan, MD, FACS to Chief Scientific Officer & Head of R&D Program. TORONTO and PHILADELPHIA, Nov. 18, 2024  -- Medicus Pharma Ltd   is pleased to announce the appointment of Faisal Mehmud, MD as Chief Medical Officer.Most recently, Dr. Mehmud was the Senior Vice President, Data Generation and Scientific Communications in Worldwide Global Medical Affairs at GlaxoSmithKline , which included leadership of medical affairs sponsored and supported, interventional and non-interventional clinical trials. Before GSK, Dr. Mehmud was with Pfizer Inc., where he served in various roles including as Vice President and Worldwide Medical Franchise Head for Precision Medicine and Early Oncology Development, advancing the precision medicine oncology portfolio in a variety of tumor types, and supporting early-stage oncology projects moving from early clinical development to full development and market readiness, effectively bridging scientific innovation with commercial strategy.Dr. Meh","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","BK4532","GSK.UK","LU0321505868.SGD","GSK","LU0321505439.SGD","MDCX","LU0289739699.SGD","LU0225284248.USD","LU1066053197.SGD","BK4533","IE000M9KFDE8.USD","SG9999001176.SGD","BK4196","LU0985481810.HKD","LU0225771236.USD","MRCP","SGXZ57979304.SGD","IE00B19Z3581.USD","LU1066051498.USD","LU1883839398.USD","LU0170899867.USD","PFE","BMS","LU1894683348.USD","BK4592","IE00BLSP4239.USD","BK4581","IE00BLSP4452.SGD","LU0058720904.USD","BK4534","BK4588","IE0002270589.USD","SG9999002232.USD","MD","BK4585","LU1057294990.SGD","SG9999013999.USD","LU1894683264.USD","LU1829250122.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","BK4007","LU0306806265.USD","LU0306807586.USD","SG9999003800.SGD","LU0868494617.USD","IE00BBT3K403.USD","BK4568"],"gpt_icon":1},{"id":"2484409156","title":"Press Release: IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2484409156","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484409156?lang=en_us&edition=fundamental","pubTime":"2024-11-18 19:00","pubTimestamp":1731927600,"startTime":"0","endTime":"0","summary":"-- Brings over 20-year global commercialization experience in oncology with. leading biopharmaceutical companies Gilead Sciences and Bristol Myers. Squibb, including leadership of multiple commercial launches for products. Prior to joining IDEAYA, Mr. Dorman was the Vice President, U.S. Oncology Business Unit Head at Gilead Sciences, where he successfully built a leading oncology commercial organization with over a billion in global annual sales, and successfully launched Trodelvy in multiple indications. Prior to that, Mr. Dorman held positions of increasing responsibility at Bristol Myers Squibb  where he built, led, and transformed global sales and marketing teams to deliver outstanding commercial execution including multiple successful launches. He concluded his 14-year tenure at BMS as Vice President, Worldwide Oncology Commercialization in its diverse oncology portfolio, including leading commercial strategy for Opdivo, Yervoy and Abraxane. He received his M.B.A. from Standford G","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","R","BK4232","BK4022","BMS","LU0566484027.USD","LU1559883803.SGD","BK4139","BK4124","DORM"],"gpt_icon":0},{"id":"2482777905","title":"Press Release: Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2482777905","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482777905?lang=en_us&edition=fundamental","pubTime":"2024-11-12 19:30","pubTimestamp":1731411000,"startTime":"0","endTime":"0","summary":"Strong growth in net product revenue of 47% y-o-y to reach $101.8. Positive China bridging study of KarXT in schizophrenia; expected. Global Phase 1 data of ZL-1310  suggests best-in-class. Three product launches in mainland China expected by the end of 2024,and up to four potential regulatory submissions to the NMPA in the next. Zai Lab Limited  today announced financial results for the third quarter of 2024, along with recent product highlights and corporate updates.\"Our net product revenues in the third quarter grew 47% y-o-y, driven by the continued strong uptake of VYVGART,\" said Josh Smiley, President and Chief Operating Officer of Zai Lab. \"VYVGART in gMG, is on track to be a blockbuster launch in its first year on China's National Reimbursement Drug List . The VYVGART franchise has tremendous potential. In addition to evaluating a variety of additional indications, we expect to launch the subcutaneous formulation of VYVGART  for gMG and chronic inflammatory demyelinating polyne","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4232","BK4139","BK4531","BK4022","BK4588","R","BMS","ZLAB","BK4548","BK4526"],"gpt_icon":0},{"id":"2482729236","title":"NXP Announces Industry-First Ultra-Wideband Wireless Battery Management System Solution","url":"https://stock-news.laohu8.com/highlight/detail?id=2482729236","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482729236?lang=en_us&edition=fundamental","pubTime":"2024-11-12 16:00","pubTimestamp":1731398400,"startTime":"0","endTime":"0","summary":"NXP has unveiled its new, industry-first wireless battery management system  solution with Ultra-Wideband  capabilities from one of the industry’s broadest UWB portfolios.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/12/2978726/0/en/NXP-Announces-Industry-First-Ultra-Wideband-Wireless-Battery-Management-System-Solution.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMS","BK4512","LU2133065610.SGD","LU1718418525.SGD","LU1861214812.USD","BK4588","LU1992135472.HKD","LU0289960550.SGD","LU2272731782.SGD","LU1823568750.SGD","BLE","LU1046421795.USD","LU0175139822.USD","LU0348723411.USD","BK4141","LU1992135399.USD","NXPI","BK4561","NXP","BK4585","LU2247934214.USD","IE00BZ199S13.USD","LU2272731600.USD","LU1861219969.SGD","LU2360107325.USD"],"gpt_icon":0},{"id":"2478125390","title":"Li-S Energy off like a rocket on latest breakthrough","url":"https://stock-news.laohu8.com/highlight/detail?id=2478125390","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478125390?lang=en_us&edition=fundamental","pubTime":"2024-10-28 15:03","pubTimestamp":1730099031,"startTime":"0","endTime":"0","summary":"Li-S Energy has made another substantial improvement to the performance of its cutting-edge lithium sulfur battery technology, sending shares up by more than 58% today. From its Phase 3 automated pouch cell production facility in Geelong Li-S Energy has achieved an industry leading close to 500Wh/kg lithium-sulfur cell performance. The development brings Li-S Energy even closer to commercialising its unique tech","market":"hk","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/10/GettyImages-181817328-1200_x_675-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/10/GettyImages-181817328-1200_x_675-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/energy/li-s-energy-off-like-a-rocket-on-latest-breakthrough/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["BMS"],"gpt_icon":0},{"id":"2477950585","title":"Redwire Announces Spaceflight Mission with Bristol Myers Squibb to Study Small Molecule Drug Compounds, Launching Additional Biopharma Investigations to Study Bone Disease Treatments in Space","url":"https://stock-news.laohu8.com/highlight/detail?id=2477950585","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477950585?lang=en_us&edition=fundamental","pubTime":"2024-10-23 19:30","pubTimestamp":1729683000,"startTime":"0","endTime":"0","summary":"JACKSONVILLE, Fla., October 23, 2024----Redwire Corporation , a leader in space infrastructure for the next generation space economy, announced today that it is launching an investigation to the International Space Station  in partnership with global leading biopharmaceutical company Bristol Myers Squibb  to study model small molecule compounds using Redwire’s pharmaceutical drug development platform . The research being conducted with BMS has the potential to enhance drug stability, streamline manufacturing processes, and improve efficiencies across various therapeutic areas, including oncology, immunology, and cardiovascular disease.Additionally, Redwire will be launching a PIL-BOX investigation in partnership with pharmaceutical startup company ExesaLibero Pharma to study the novel drug ELP-004, which prevents excess bone removal associated with numerous diseases, including rheumatoid arthritis, multiple myeloma, and breast and prostate cancers. These newest spaceflight investigatio","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Trphma6aK.CtsO74fgANwQ--~B/aD0yNzA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/12b84fa6c729edd3a38055547e2558d1","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Trphma6aK.CtsO74fgANwQ--~B/aD0yNzA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/12b84fa6c729edd3a38055547e2558d1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/redwire-announces-spaceflight-mission-bristol-113000872.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BMY","RDW","BMS","MYE","BK4187","BK4126"],"gpt_icon":0},{"id":"2477533533","title":"At electronica 2024, Alpha and Omega Semiconductor to Showcase its Application-Specific Solutions for Auto, Industrial, Power Supplies, Renewable Energy, e-Mobility and More","url":"https://stock-news.laohu8.com/highlight/detail?id=2477533533","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477533533?lang=en_us&edition=fundamental","pubTime":"2024-10-22 20:00","pubTimestamp":1729598400,"startTime":"0","endTime":"0","summary":"Editors and customers are invited to meet with AOS product experts to learn how it has engineered its latest products to solve important power management design challenges. Automotive and Industrial: AOS Gen2 SiC MOSFETs support the needs of a wide array of automotive and industrial applications with its latest advanced packages. AOS offers two AEC-Q101 automotive-qualified surface mount options for extreme power density, including a standard D2PAK-7L and the GTPAKTM with surface mount topside cooling featuring a Kelvin source for the highest efficiency. AOS has several SiC modules that meet higher power charging stations and industrial solar inverter design requirements. Also displayed will be AOS’ comprehensive line 10mOhm-500mOhm, 650V-1700V SiC MOSFETs.Automotive and E-mobility: In AOS’ increasing line of automotive MOSFETs, the new automotive-grade 80V  and 100V  MOSFETs in the TOLL package are designed to achieve the highest current capability. The AOS TOLL package utilizes advan","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/pAW.wMfWrULQF32BuqC_xg--~B/aD0yMDM7dz05Mjg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3da343526524df111063926a1ac0a325","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/pAW.wMfWrULQF32BuqC_xg--~B/aD0yMDM7dz05Mjg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3da343526524df111063926a1ac0a325"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/electronica-2024-alpha-omega-semiconductor-120000496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1165135440.EUR","LU2413665964.HKD","PW","LU1620156213.USD","LU1543694498.USD","LU1596574779.USD","LU1620156130.USD","BK4084","BK4141","BK4585","AOSL","LU1721427968.SGD","BMS","BK4234","BK4588","AOS","LU2413666004.HKD","BK4086"],"gpt_icon":0},{"id":"2474584332","title":"JOHNSON CONTROLS TO SHOWCASE SMARTER, SAFER, AND MORE RESILIENT DATA CENTRE SOLUTIONS AT DATA CENTRE WORLD ASIA 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2474584332","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474584332?lang=en_us&edition=fundamental","pubTime":"2024-10-09 09:32","pubTimestamp":1728437520,"startTime":"0","endTime":"0","summary":"Key executives to share insights on sustainable data centre infrastructure and innovation to address key challenges and drive best practices for a more sustainable future.SINGAPORE, Oct. 9, 2024 /PRNewswire/ -- Johnson Controls , the global leader for smart, healthy and sustainable buildings, is participating in Data Centre World Asia 2024, where the company will showcase its cutting-edge solutions for the rapidly growing data centre industry. With over 140 years of innovation, Johnson Controls delivers sustainable infrastructure, advanced technology, and integrated solutions that optimize performance, energy efficiency, and security in mission-critical environments like data centres.\"In a world where data centres consume up to 50 times more energy than traditional buildings, our focus on sustainable infrastructure has never been more critical,\" said Anu Rathninde, President, Asia Pacific, Johnson Controls. \"Our focus on customized and integrated solutions empowers data centres to oper","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/IJQ6EvN6Xgc1lA2Et2mYgQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/fe5f65b10ac40aad281e7a84d2a01c18","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/IJQ6EvN6Xgc1lA2Et2mYgQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/fe5f65b10ac40aad281e7a84d2a01c18"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/johnson-controls-showcase-smarter-safer-013200892.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-controls-showcase-smarter-safer-013200892.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z9Z06.USD","BK4086","LU0208291251.USD","ASIA","LU1854103824.USD","LU0124384867.USD","BK4580","LU0211331839.USD","JCI","IE00BZ9MQY76.HKD","LU0312595415.SGD","LU0320765489.SGD","IE00B894F039.SGD","LU1854104046.USD","LU1989764748.USD","IE00B19Z9P08.USD","BK4504","LU1989764664.SGD","LU0070302665.USD","BK4588","MORE","LU1978683503.SGD","BK4585","BMS"],"gpt_icon":0},{"id":"2472934406","title":"Leidos touts small cruise missile solution, announces successful test accomplishments","url":"https://stock-news.laohu8.com/highlight/detail?id=2472934406","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472934406?lang=en_us&edition=fundamental","pubTime":"2024-10-03 18:00","pubTimestamp":1727949600,"startTime":"0","endTime":"0","summary":"RESTON, Va., Oct. 3, 2024 /PRNewswire/ -- Leidos , an industry leader in national security and health, announced today that its Small Cruise Missile  -- nicknamed the \"Black Arrow\" in recognition of its range and lethality -- has successfully completed captive carry and store safe separation flight tests in preparation for guided flight tests from a U.S. Air Force Special Operations Command  aircraft scheduled for this fall.Store separation testing from an AC-130J, conducted in December 2023, confirmed digital twin predictions of safe separation, benign store dynamics, and trajectory characteristics. Additional captive flight testing demonstrated integration with the NSWC Battle Management System , operational flight software function, navigation performance, and flight safety system functionality.Leidos is a Fortune 500 innovation company rapidly addressing t","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_BP5jn1WuJ8zmVfCnqmarA--~B/aD0zNjI7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/89c269b77768b84bd50669de3ff4fcb3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_BP5jn1WuJ8zmVfCnqmarA--~B/aD0zNjI7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/89c269b77768b84bd50669de3ff4fcb3"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/leidos-touts-small-cruise-missile-100000616.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/leidos-touts-small-cruise-missile-100000616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","LDOS","BK4135","BK4123","SCM","BK4588","LU0006061336.USD","BMS"],"gpt_icon":0},{"id":"2472893309","title":"Shattuck Labs Shutters Cancer Program, Lays Off Around 40% Of Its Workforce, Reorganizes Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2472893309","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472893309?lang=en_us&edition=fundamental","pubTime":"2024-10-02 00:26","pubTimestamp":1727800016,"startTime":"0","endTime":"0","summary":"On Tuesday, Shattuck Labs, Inc.  stock traded lower, with a session volume of 9.48 million versus the average volume of 328.32k. The company announced a strategic pipeline prioritization.Shattuck will discontinue its clinical program, SL-172154, and focus on SL-325, its DR3 antagonist antibody. Shattuck Labs plans to initiate clinical development in patients with inflammatory bowel disease.Approximately 40% of Shattuck’s workforcewill beimpacted by the changes. The company expects to complete the reduction in force in the fourth quarter of 2024.The company says its cash and cash equivalents and investments will be sufficient to fund its planned operations into 2027.Shattuck expects to file an investigational new drug for SL-325 in the third quarter of 2025. Topline Phase 1B SL-172154 trial in higher-risk myelodysplastic syndromes  showed median overall survival of 15.6 months. The median survival for patients with TP53m HR-MDS is 10.6 months and will not improve beyond 13.1 months with","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/dBxgmbteeJOqQ.vcuRTbgw--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/a44cefe8a9a6d61d4dcabaede6230f3e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/dBxgmbteeJOqQ.vcuRTbgw--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/a44cefe8a9a6d61d4dcabaede6230f3e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/shattuck-labs-shutters-cancer-program-162656279.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BMS","STTK","BK4139"],"gpt_icon":0}],"pageSize":16,"totalPage":3,"pageCount":3,"totalSize":43}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-01-29","symbol":"BMS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1580274000000,"reportTimeType":"pre","actualEps":null},{"date":"2019-10-23","symbol":"BMS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1571817600000,"name":null,"time":"Pre-Market","dateTimestamp":1571803200000,"actualEps":null},{"market":"US","date":"2019-04-26","symbol":"BMS","amount":0.32,"name":"碧美斯","payableDate":"2019-04-29","currency":"USD","type":"dividend","dateTimestamp":1556251200000},{"market":"US","date":"2019-04-22","symbol":"BMS","fiscalQuarterEnding":"2019/03","expectedEps":0.66,"name":null,"time":"","type":"earning","dateTimestamp":1555905600000,"reportTimeType":"","actualEps":0.67},{"market":"US","date":"2019-02-19","symbol":"BMS","amount":0.32,"name":"碧美斯","currency":"USD","type":"dividend","dateTimestamp":1550552400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMS\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-16","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2017-05-15","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2017-08-15","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2017-11-14","recordDate":null,"paymentDate":null,"value":0.3,"currency":"USD"},{"executeDate":"2018-02-16","recordDate":null,"paymentDate":null,"value":0.31,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMS\",market:\"US\",delay:false,,,undefined,":{}}}